Infection Control Market Scenario
Market Research Future (MRFR) expects the global infection control market to rise at a CAGR of close to 7.5% during the forecast period (2017-2023).
Growth Drivers and Top Barriers
The infection control market gets a boost from the rise in surgical procedures requiring high-intensity infection prevention. The growing preference is believed to be the result of positive clinical outcomes linked with the use of infection control.
The hike in the number of government initiatives with the aim of infection prevention is thought to be the chief factor driving the market. Furthermore, government organizations are progressively issuing guidelines for promoting awareness about efficient prevention measures worldwide. This is a crucial factor expected to work in favor of the market.
World Health Organization (WHO) deems Acute Respiratory Diseases (ARDs) as one of the significant causes leading to death across the globe. Roughly 4.0 million deaths are caused by ARDs every year. These numbers exemplify the rising need for strict prevention as well as control. It is predicted that prolonged hospital stay is uneconomical for hospitals as well as healthcare payers with the excessive use of resources for treating acquired infections. These extra costs are mostly generated with the high usage of drugs, laboratory equipment, additional diagnostic studies, which leads to resource allocation imbalance. This factor has accelerated the demand for infection control market across the globe and is expected to increase further in the following years.
Infection Control Market Segmentation
The worldwide market for infection control has been segmented on the basis of type and end-user.
Type-wise, the infection control market is considered for disinfection products, sterilization products and services, and others. The disinfection product includes disinfectants, medical nonwovens, disinfectors, and endoscope reprocessors.
The end-users in the global infection control market are hospitals and clinics, life sciences industry, medical device companies, pharmaceutical companies, food industry, and others.
Infection Control Market Regional Insight
The main markets for infection control market are Europe, America, Middle East & Africa, and Asia Pacific.
The Americas is believed to rise as the most lucrative infection control market backed by the rising awareness about chronic infections combined with the surging number of service providers. The United States (U.S.) covers the maximum share of the regional market for infection control on account of the presence of sophisticated healthcare infrastructure and highly developed medical technologies.
It is quite likely that Europe could emerge as the second leading market for infection control. The presence of developed research and development facilities along with a slew of technological advancements is expected to fetch excellent revenues during the evaluation time frame.
The Asia Pacific market can expect the fastest growth during the review period with the surge in healthcare expenditure and superlative healthcare standards and infrastructure. Also, the boost in the number of outsourcing organizations in the region will benefit the market in the forthcoming years. For example, a voluntary organization known as Asia Pacific Society of Infection Control (APSIC) indulge in collaborations and partnerships as well as infection control researches to promote cost-efficient practices throughout the region. The regional market also gains momentum on the back of various government organizations committed to elevating the standards for infection control.
Middle East and Africa is perceived to develop steadily in the coming years based on the extensive advancement of the healthcare infrastructure coupled with the rising R&D activities within the healthcare sector.
Infection Control Market Key Participants
The esteemed players shaping the worldwide infection control market include Honeywell International, Inc. (U.S.), Cantel Medical Corporation (U.S.), Ahlstrom Corporation (Finland), STERIS Corporation (U.K.), Getinge Group (Sweden), MMM Group (Germany), Advanced Sterilization Products (U.S.), Ecolab (U.S.), Belimed AG (Switzerland), Sotera Health (U.S.), Metrex Research (U.S.), Reckitt Benckiser (U.K.), Matachana (Spain), 3M Healthcare Company (U.S.), Halyard Health (U.S.), Pal Internation (U.K.), Nordion, Inc. (U.S.), to name a few.
Browse Full Report with TOC at: https://www.marketresearchfuture.com/reports/infection-control-market-5901
Infection Control Industry Latest News
June 2019: Medline has launched its first infection control product, Micro-Kill Bleach Germicidal Bleach Wipes, after getting clearance from EPA. This product is highly efficient in disinfecting hospital surfaces, which is home to C. Auris, an infection causing fungus.
